Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
No peer-reviewed clinical trial data confirm a direct pharmacological link between retatrutide and changes in libido or sexual function
The PlexusDx Precision Peptide Genetic Test identifies variants like MC4R rs17782313 that influence how your body's GLP-1 receptors respond to both natural food signals and medication
Product Detail Product Tags Brief Introduction: Retatrutide is an active compound released by Eli Lilly in June 2023
Both the Kidney Disease Improving Global Outcomes guidelines and American Diabetes Association Standards of Care recommend GLP1-RA as the preferred glucose lowering class for people with T2D and moderate to advanced CKD or ESRD because of their demonstrated cardiovascular benefits in people with T2D at high risk of cardiovascular disease, which includes CKD 13,14
